在墨西哥阿瓜斯卡利昂特斯 (Aguascalientes) 的住宅中心寻求甲基胺治疗的障碍
Kalina Isela Martínez Martínez1, Yancarlo Lizandro Ojeda Aguilar1, Lorenia Robles Villarreal1
1Department of Psychology, Autonomous University of Aguascalientes, Aguascalientes, Mexico.
Frontiers in psychology
|September 6, 2023
概括
年轻的吸毒者面临更多的治疗障碍和问题. 早期开始使用甲与在住院治疗中心增加的障碍和与消费有关的问题有关.
科学领域:
- 成 药物 药物 药物 药物
- 心理学 心理学 心理学
- 公共卫生 公共卫生
背景情况:
- 在阿瓜斯卡利昂特斯 (Aguascalientes) 寻求因使用甲基胺而接受治疗的大多数个人都参加非政府住宅中心.
- 墨西哥人群中寻求治疗的障碍存在有限的研究,特别是在住宅中心用户中.
研究的目的:
- 探索在住宅中心的甲基胺使用者中寻求治疗的障碍.
- 检查报告的障碍与甲基胺使用模式之间的关系.
- 根据障碍和消费模式识别用户配置文件.
主要方法:
- 一项调查评估了社会人口结构,消费模式,寻求帮助的行为,障碍,抑郁和自杀企图.
- 这项研究包括865名在23个经过认证的住所中心接受甲基胺使用治疗的个人.
- 使用k-means算法进行集群分析,确定了用户配置文件.
主要成果:
- 患者报告平均有2.12个障碍,其中常见的问题包括感知到缺乏有用性,感知到重要性很低和时间限制.
- 在障碍的数量和甲基开始的年龄,感知风险,戒烟尝试和相关问题之间发现了一个微弱但显著的关系.
- 两个群体出现了:年轻的用户有更多的问题和障碍,老年用户有更少的问题和障碍. 年轻的使用者也报告了更高的物质消费和更多的相关问题.
结论:
- 开始使用甲基胺的年龄是遇到更多与消费相关的障碍和问题的重要风险因素.
- 了解这些障碍对于改善住宅环境中甲基胺使用者的治疗可及性和治疗结果至关重要.
相关概念视频
01:28Drug Therapy
68
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
68
01:17Drug Dependence
1.0K
Medications are typically administered to achieve therapeutic effects. Some drugs can modify an individual's mood and perception, frequently resulting in various enjoyable experiences. However, this can result in drug dependency, a condition marked by continuous drug use despite potential negative consequences. Drug dependency primarily falls into two categories: psychological and physical dependence. Psychological dependence occurs when the pleasurable feelings induced by the drug...
1.0K
01:30Specialized Care Centers and Settings-I
969
Specialized care settings or centers are situated in convenient locations within the community and offer care to a specific group or population. They consist of daycare facilities, mental health facilities, rural health facilities, educational institutions, industries, shelters for the homeless, and rehabilitation facilities.
Daycare centers
They provide several functions. Some facilities care for healthy newborns and children whose parents work, while others are medically focused and care for...
Daycare centers
They provide several functions. Some facilities care for healthy newborns and children whose parents work, while others are medically focused and care for...
969
01:15Drug Abuse and Addiction: Pharmacological Phenomena
508
Drug dependence, abuse, and addiction are complex phenomena that can precipitate various abnormal states. Physical dependence refers to a state of pharmacological adaptation to a drug. This adaptation often results in tolerance—a reduced response to the drug after repeated administrations. When the drug use is abruptly stopped, withdrawal symptoms occur due to the body's need to readjust from the pharmacologically induced imbalance. However, tolerance and withdrawal symptoms do not...
508
01:26Psychosis: Goals of Pharmacotherapy
165
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
165
01:28Adrenergic Agonists: Mixed-Action Agents
778
Mixed-action adrenergic agonists, like ephedrine and pseudoephedrine, directly and indirectly affect adrenergic receptors. These agents stimulate adrenoceptors and indirectly release stored neurotransmitters, amplifying the adrenergic response.
Ephedrine and pseudoephedrine lack a catecholamine group, making them less susceptible to degradation by metabolic enzymes. They have increased oral bioavailability and lipophilicity, resulting in a longer duration of action. Their response is reduced by...
Ephedrine and pseudoephedrine lack a catecholamine group, making them less susceptible to degradation by metabolic enzymes. They have increased oral bioavailability and lipophilicity, resulting in a longer duration of action. Their response is reduced by...
778